Eelke Gort

1.2k total citations
29 papers, 561 citations indexed

About

Eelke Gort is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Eelke Gort has authored 29 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 8 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Eelke Gort's work include Cancer, Hypoxia, and Metabolism (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Peptidase Inhibition and Analysis (5 papers). Eelke Gort is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Peptidase Inhibition and Analysis (5 papers). Eelke Gort collaborates with scholars based in Netherlands, United States and United Kingdom. Eelke Gort's co-authors include Marc Vooijs, Arjan J. Groot, P. J. van Diest, Elsken van der Wall, Paul van Diest, Venu Raman, Karijn P.M. Suijkerbuijk, Анна Шварц, Ingrid Verlaan and Theo van Laar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Eelke Gort

26 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eelke Gort Netherlands	12	338	200	197	63	45	29	561
Amanda R. Wasylishen United States	15	465 1.4×	257 1.3×	179 0.9×	68 1.1×	21 0.5×	25	643
Maider Ibarrola‐Villava Spain	16	310 0.9×	214 1.1×	136 0.7×	52 0.8×	42 0.9×	31	658
Verónica Calvo United States	9	265 0.8×	218 1.1×	167 0.8×	51 0.8×	23 0.5×	13	513
Kym L. Stanley Australia	9	588 1.7×	310 1.6×	123 0.6×	59 0.9×	45 1.0×	10	893
Е. М. Slonimskaya Russia	15	320 0.9×	307 1.5×	173 0.9×	94 1.5×	23 0.5×	93	617
Tara M. Lichtenberg United States	3	346 1.0×	150 0.8×	193 1.0×	77 1.2×	14 0.3×	7	635
Josephine Iaria Australia	11	308 0.9×	203 1.0×	92 0.5×	35 0.6×	31 0.7×	14	459
Sara D’Andrea Italy	13	448 1.3×	350 1.8×	316 1.6×	95 1.5×	51 1.1×	23	807
Markéta Žaliová Czechia	18	348 1.0×	111 0.6×	177 0.9×	27 0.4×	27 0.6×	59	974
Mohamad A. Salkeni United States	11	317 0.9×	237 1.2×	140 0.7×	99 1.6×	57 1.3×	42	603

Countries citing papers authored by Eelke Gort

Since Specialization

Citations

This map shows the geographic impact of Eelke Gort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eelke Gort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eelke Gort more than expected).

Fields of papers citing papers by Eelke Gort

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eelke Gort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eelke Gort. The network helps show where Eelke Gort may publish in the future.

Co-authorship network of co-authors of Eelke Gort

This figure shows the co-authorship network connecting the top 25 collaborators of Eelke Gort. A scholar is included among the top collaborators of Eelke Gort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eelke Gort. Eelke Gort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hami, Nizar, Hans W. Nijman, Jurgen M.J. Piek, et al.. (2025). The Prognostic Value of FOXL2 Mutant Circulating Tumor DNA in Adult Granulosa Cell Tumor Patients. Cancers. 17(11). 1894–1894.

Groeneweg, Jolijn W., et al.. (2025). Signal transduction pathway activity in adult-type granulosa cell tumor samples. Gynecologic Oncology. 195. 6–11.

Groeneweg, Jolijn W., Hans W. Nijman, Christianne Lok, et al.. (2025). Is it time to abandon staging surgery and prolonged follow-up in patients with primary adult-type granulosa cell tumor?. Journal of Ovarian Research. 18(1). 37–37. 1 indexed citations

Teske, Arco J., Adriaan O. Kraaijeveld, Lysette N. Broekhuizen, et al.. (2024). Intracardiac echocardiography‐guided biopsies for right‐sided intracardiac tumors: An optimized diagnostic algorithm and case illustrations. Catheterization and Cardiovascular Interventions. 104(4). 862–868. 1 indexed citations

Jonge, Maja J.A. de, Eelke Gort, Jeroen Hasselaar, et al.. (2024). Patient values in patient-provider communication about participation in early phase clinical cancer trials: a qualitative analysis before and after implementation of an online value clarification tool intervention. BMC Medical Informatics and Decision Making. 24(1). 32–32.

Steeghs, Neeltje, Carlos Gomez‐Roca, Eelke Gort, et al.. (2024). Effect of MP0317, a FAP x CD40 DARPin, on safety profile and tumor-localized CD40 activation in a phase 1 study in patients with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 2573–2573. 2 indexed citations

Brandão, Mariana, J.T.J.N. Hiltermann, Els Wauters, et al.. (2023). 1446P Preliminary efficacy and safety of rilvegostomig (AZD2936), a bispecific antibody targeting PD-1 and TIGIT, in checkpoint inhibitor (CPI)-pretreated advanced/metastatic non-small-cell lung cancer (NSCLC): ARTEMIDE-01. Annals of Oncology. 34. S822–S823. 6 indexed citations

Tahir, Stephen K., Emiliano Calvo, Benedito A. Carneiro, et al.. (2023). Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia. Blood. 141(17). 2114–2126. 9 indexed citations

Gomez‐Roca, Carlos, Neeltje Steeghs, Eelke Gort, et al.. (2023). Phase I study of MP0317, a FAP-dependent DARPin, for tumor-localized CD40 activation in patients with advanced solid tumors.. Journal of Clinical Oncology. 41(16_suppl). 2584–2584. 3 indexed citations

10.

Laclé, Miangela M., et al.. (2022). 364P Prevalence, treatment and survival of NTRK gene fusions in microsatellite instable metastatic colorectal cancer patients. Annals of Oncology. 33. S703–S703. 2 indexed citations

11.

Winter, Hilde De, Vaia Stavropoulou, Paul Baverel, et al.. (2022). 1475 A phase 1 study to characterize the safety and tolerability of MP0317, a tumor targeting FAP dependent CD40 agonist DARPin, in patients with relapsed/refractory solid tumors. A1534–A1534. 1 indexed citations

12.

Jeger, Simone, Oliver Schönborn‐Kellenberger, Hilde De Winter, et al.. (2021). 170TiP A phase I study to characterize the safety and tolerability of MP0317, a tumor targeting FAP dependent CD40 agonist DARPin®, in patients with relapsed/refractory solid tumors. Annals of Oncology. 32. S1456–S1457. 1 indexed citations

13.

Johnson, Melissa L., Eelke Gort, Shubham Pant, et al.. (2021). 524P A phase I, open-label, dose-escalation trial of BI 1701963 in patients (pts) with KRAS mutated solid tumours: A snapshot analysis. Annals of Oncology. 32. S591–S592. 23 indexed citations

14.

Vergote, Ignace, Bradley J. Monk, Anneke M. Westermann, et al.. (2021). 723MO Tisotumab vedotin (TV) + carboplatin (Carbo) in first-line (1L) or + pembrolizumab (Pembro) in previously treated (2L/3L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT-Cx8/GOG-3024/innovaTV 205 study. Annals of Oncology. 32. S726–S727. 12 indexed citations

15.

Linschoten, Marijke, Maarten J. Cramer, Eelke Gort, et al.. (2019). Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics. JACC CardioOncology. 1(2). 280–290. 21 indexed citations

16.

Weert, Julia C.M. van, Jelle van Gurp, Maja J.A. de Jonge, et al.. (2019). Realizing better doctor-patient dialogue about choices in palliative care and early phase clinical trial participation: towards an online value clarification tool (OnVaCT). BMC Palliative Care. 18(1). 106–106. 8 indexed citations

17.

Vooijs, Marc, et al.. (2008). Hypoxic Regulation of Metastasis via Hypoxia-Inducible Factors. Current Molecular Medicine. 8(1). 60–67. 99 indexed citations

18.

Cuppen, Edwin, Eelke Gort, Esther Hazendonk, et al.. (2007). Efficient target-selected mutagenesis in Caenorhabditis elegans: Toward a knockout for every gene. Genome Research. 17(5). 649–658. 25 indexed citations

19.

Gort, Eelke, Gijs van Haaften, Ingrid Verlaan, et al.. (2007). The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2α. Oncogene. 27(11). 1501–1510. 110 indexed citations

20.

Groot, Arjan J., Peter Verheesen, Eelke Gort, et al.. (2006). Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha. Laboratory Investigation. 86(4). 345–356. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact